GlassScriptPhysician profile
Julia A Carter
NPI 1164692935
$3,959.52
in general payments reported to CMS, 2019-2025
22 companies · $598 in 2025
The $598 reported for 2025 was more than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $368 · 2020: $10.10 · 2021: $687 · 2022: $870 · 2023: $840 · 2024: $585 · 2025: $598.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,024.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,023.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,002.01 | 2022-2025 | Durysta, Alphagan P, Lumigan |
| Allergan, INC. | $457.10 | 2019-2022 | |
| Bausch & Lomb Americas INC. | $415.44 | 2022-2025 | Miebo, Xiidra, Vyzulta |
| Alcon Vision LLC | $331.61 | 2022-2025 | Hydrus Microstent, Rocklatan, Tryptyr |
| Glaukos Corporation | $269.03 | 2023-2025 | Istent Infinite Trabecular Micro-Bypass System Model Is3, Idosetr |
| Ocular Therapeutix, INC. | $256.19 | 2022-2025 | Dextenza |
| Sight Sciences, INC. | $189.57 | 2022-2025 | Sion Surgical Instrument, Omni Surgical System |
| Horizon Therapeutics Plc | $183.18 | 2021-2022 | |
| Aerie Pharmaceuticals, INC. | $169.32 | 2019-2021 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $150.79 | 2019 | |
| Sun Pharmaceutical Industries INC. | $137.69 | 2021 | |
| Kala Pharmaceuticals, INC. | $89.38 | 2019-2022 | |
| Novartis Pharmaceuticals Corporation | $72.31 | 2019-2023 | |
| Rayner Intraocular Lenses Limited | $56.50 | 2022-2025 | Omidria, Rayone Emv, Rayone Spheric |
| Dompe US, INC. | $49.05 | 2025 | Oxervate |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mallinckrodt Hospital Products INC. | $24.75 | 2021 | |
| Tarsus Pharmaceuticals, INC. | $24.08 | 2025 | Xdemvy |
| Merz Pharmaceuticals, LLC | $19.96 | 2025 | Xeomin |
| Harrow Eye, LLC | $17.67 | 2025 | Vevye |
| Rxsight INC | $17.18 | 2024 | Rxsight Injector Handpiece, Light Adjustable Lens (Lal), Rxsight Injector Cartridge |
| Iridex Corporation | $16.61 | 2019 | |
| Lensar, INC. | $10.10 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Julia Carter listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.